Skip to main content

Table 1 Body weight and renal mass

From: Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1

GROUPS

CTL

BUT

LET

LET + BUT

Initial Body weight (g)

131.20 ± 3.90

133.80 ± 4.76

142.40 ± 3.50

131.80 ± 3.08

Body weight gain (g)

26.40 ± 2.59

35.67 ± 1.73

48.40 ± 5.95*

39.60 ± 6.29#

Renal mass (g/kg)

6.14 ± 0.08

6.13 ± 0.13

6.55 ± 0.10*

5.98 ± 0.17#

  1. Data are expressed as mean ± S.D. n = 5. Data were analyzed by one-way ANOVA followed by Bonferroni post hoc test. (*P < 0.05 vs. CTL; #P < 0.05 vs. LET). (Control (CTL); Butyrate (BUT); Letrozole (LET).
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us